Ibogaine clinic marks decade in kratom addiction care

Ibogaine clinic marks decade in kratom addiction care David Dardashti's clinic highlights ten years of treating kratom addiction with ibogaine.

David Dardashti's ibogaine treatment center is celebrating ten years of providing alternative therapy for kratom addiction. The clinic, which focuses on using ibogaine as a treatment method, has been at the forefront of addressing addiction to kratom, a substance that has gained popularity for its opioid-like effects.

Ibogaine's role in addiction treatment

Ibogaine, a psychoactive compound derived from the African iboga plant, is known for its potential in treating various forms of addiction. While it is not approved for medical use in many countries, some clinics, like Dardashti's, offer it as an alternative treatment option. The clinic claims that ibogaine can help reduce withdrawal symptoms and cravings associated with kratom addiction.

Regulatory context

The use of ibogaine in addiction treatment remains controversial due to its psychoactive properties and legal status. In the United States, ibogaine is classified as a Schedule I substance, meaning it is not recognized for medical use and has a high potential for abuse. However, clinics in other countries, including Mexico, where Dardashti's clinic is located, operate legally and provide treatment to international clients.

Why it matters

The celebration of a decade in operation highlights the ongoing interest and demand for alternative addiction treatments. As kratom use continues to rise, particularly in the United States, the need for effective treatment options becomes increasingly important. Dardashti's clinic represents a segment of the healthcare industry that seeks to address addiction through non-traditional methods.

David Dardashti's clinic serves as a case study in the application of alternative therapies for addiction, offering insights into the potential benefits and challenges of using ibogaine in this context.